EUVIMEDEUVIMED entdecken
Crossref

A Novel Coacervate Embolic Agent for Tumor Chemoembolization

Menghui Liu, Yang Sun, Yitong Zhou, Yanlv Chen, Meng Yu, Liujun Li, Leye Yan, Yajun Yuan, Jiayao Chen, Kaixiang Zhou, Hong Shan iD, Xin Peng iD

Advanced Healthcare Materials · 2024-07 · 13 (19)

DOI: 10.1002/adhm.202304488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 13.04.2024. Verfasst von Menghui Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China. Hauptthemen laut MEDLINE: Chemoembolization, Therapeutic, Doxorubicin, Chitosan. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcatheter arterial chemoembolization (TACE) has proven effective in blocking tumor‐supplied arteries and delivering localized chemotherapeutic treatment to combat tumors. However, traditional embolic TACE agents exhibit certain limitations, including insufficient chemotherapeutic drug‐loading and sustained‐release capabilities, non‐biodegradability, susceptibility to aggregation, and unstable mechanical properties. This study introduces a novel approach to address these shortcomings by utilizing a complex coacervate as a liquid embolic agent for tumor chemoembolization. By mixing oppositely charged quaternized chitosan (QCS) and gum arabic (GA), a QCS/GA polymer complex coacervate with shear‐thinning property is obtained. Furthermore, the incorporation of the contrast agent Iohexol (I) and the chemotherapeutic doxorubicin (DOX) into the coacervate leads to the development of an X‐ray‐opaque QCS/GA/I/DOX coacervate embolic agent capable of carrying drugs. This innovative formulation effectively embolizes the renal arteries without recanalization. More importantly, the QCS/GA/I/DOX coacervate can successfully embolize the supplying arteries of the VX2 tumors in rabbit ear and liver. Coacervates can locally release DOX to enhance its therapeutic effects, resulting in excellent antitumor efficacy. This coacervate embolic agent exhibits substantial potential for tumor chemoembolization due to its shear‐thinning performance, excellent drug‐loading and sustained‐release capabilities, good biocompatibility, thrombogenicity, biodegradability, safe and effective embolic performance, and user‐friendly application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemoembolization, TherapeuticDoxorubicinChitosanAnimalsRabbitsGum ArabicCell Line, TumorIohexolContrast MediaMice

Stichwörter der Autor:innen

VX2 tumorcoacervateliquid embolic agenttranscatheter arterial chemoembolization

Substanzen

DoxorubicinChitosanGum ArabicIohexolContrast Media

Autor:innen und Institutionen

  • Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
  • Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
  • Department of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
  • Department of Neonatology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
  • Department of Ultrasound, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
  • Center for Advanced Materials Research, Beijing Normal University, Zhuhai, 519087, China.

ORCID-Profile: Hong Shan, Xin Peng

Förderung

  • National Natural Science Foundation of China
  • Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine Foundation of Guangdong Province

Zitieren

APA

Liu, M., Sun, Y., Zhou, Y., Chen, Y., Yu, M., Li, L., Yan, L., Yuan, Y., Chen, J., Zhou, K., Shan, H., & Peng, X. (2024). A Novel Coacervate Embolic Agent for Tumor Chemoembolization. Advanced Healthcare Materials, 13(19). https://doi.org/10.1002/adhm.202304488

Vancouver

Liu M, Sun Y, Zhou Y, Chen Y, Yu M, Li L, et al. A Novel Coacervate Embolic Agent for Tumor Chemoembolization. Advanced Healthcare Materials. 2024;13(19). doi:10.1002/adhm.202304488

BibTeX
@article{Liu2024,
  author = {Liu, Menghui and Sun, Yang and Zhou, Yitong and Chen, Yanlv and Yu, Meng and Li, Liujun and Yan, Leye and Yuan, Yajun and Chen, Jiayao and Zhou, Kaixiang and Shan, Hong and Peng, Xin},
  title = {A Novel Coacervate Embolic Agent for Tumor Chemoembolization},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {19},
  doi = {10.1002/adhm.202304488}
}
Kostenlos starten →